Actionnariat et activité des initiés pour Werewolf Therapeutics, Inc. (HOWL): transactions des initiés, déclarations de trading du Sénat et de la Chambre américaine et actions en circulation. Suivez comment dirigeants et politiciens négocient le titre.
Prix
| Prix | $0.92 |
| Capitalisation | $45M |
| Bourse | NASDAQ |
| Pays | US |
Transactions d'Initiés Récentes
| Date | Initié | Type | Actions | Valeur |
|---|---|---|---|---|
| 2026-07-06 | EVNIN LUKE | S-Sale | 35,770 | $11K |
| 2026-07-07 | EVNIN LUKE | S-Sale | 107,429 | $33K |
| 2026-06-29 | EVNIN LUKE | S-Sale | 157,084 | $47K |
| 2026-06-17 | RA CAPITAL MANAGEMENT, L.P. | S-Sale | 389,216 | $136K |
| 2026-06-17 | RA CAPITAL MANAGEMENT, L.P. | S-Sale | 27,695 | $10K |
| 2026-06-12 | RA CAPITAL MANAGEMENT, L.P. | S-Sale | 159,119 | $64K |
| 2026-06-15 | RA CAPITAL MANAGEMENT, L.P. | S-Sale | 120,216 | $47K |
| 2026-06-16 | RA CAPITAL MANAGEMENT, L.P. | S-Sale | 139,686 | $52K |
| 2026-06-12 | RA CAPITAL MANAGEMENT, L.P. | S-Sale | 11,322 | $5K |
| 2026-06-15 | RA CAPITAL MANAGEMENT, L.P. | S-Sale | 8,554 | $3K |
Bilan (10 ans)
| Année | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Trésorerie | $17.9M | $92.6M | $157.5M | $129.3M | $134.3M | $111.0M | $58.0M |
| Placements à Court Terme | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Créances | 0 | 0 | 0 | $6.9M | $1.4M | 0 | 0 |
| Stocks | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Actifs Courants | $18.1M | $92.9M | $161.1M | $140.2M | $138.4M | $113.1M | $58.6M |
| Immobilisations Corporelles | $3.4M | $3.1M | $16.3M | $17.5M | $14.8M | $12.3M | $9.9M |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Actifs Incorporels | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Actifs Totaux | $21.7M | $96.4M | $179.2M | $160.2M | $174.8M | $126.9M | $69.4M |
| Dettes Fournisseurs | $633000 | $1.0M | $2.0M | $1.2M | $1.3M | $3.0M | $754000 |
| Dette à Court Terme | 0 | 0 | 0 | 0 | $6.7M | 0 | $1.8M |
| Passifs Courants | $2.0M | $5.3M | $11.9M | $24.0M | $19.4M | $15.2M | $36.1M |
| Dette à Long Terme | 0 | 0 | 0 | 0 | $32.7M | $26.1M | 0 |
| Passifs Totaux | $11.9M | $7.2M | $26.5M | $37.9M | $63.5M | $53.5M | $44.6M |
| Réserves | -$24.4M | -$51.9M | -$252.9M | -$306.7M | -$344.1M | -$414.6M | -$475.4M |
| Capitaux Propres | $9.8M | $89.2M | $152.8M | $122.3M | $111.4M | $73.4M | $24.8M |
| Dette Totale | $3.1M | $2.5M | $15.7M | $14.7M | $51.9M | $37.1M | $9.4M |
| Dette Nette | -$14.8M | -$90.0M | -$141.9M | -$114.6M | -$82.4M | -$73.9M | -$48.5M |
| Fonds de Roulement | $16.0M | $87.6M | $149.2M | $116.2M | $119.0M | $97.9M | $22.4M |
Santé financière
| Dette / Capitaux propres | 0.00 |
| Ratio de liquidité | 2.91 |
| Piotroski F-Score | 2 |
| Altman Z-Score | -11.70 |
Rentabilité
| Rentabilité des capitaux propres | -245.20% |
| Rentabilité du capital investi | -173.37% |
| Rentabilité des actifs | -87.64% |
| Marge brute | 86.43% |
| Marge opérationnelle | -121.78% |
| Marge nette | -164.82% |
Entreprises liées: ACET · CUE · INMB · IOBT · LITS · NRXP · OSTX
Explorer le secteur: Healthcare · Biotechnology
Plus de sections de HOWL: Vue d'ensemble · Financiers · Valorisation · Statistiques · Estimations · Technique · Actualités · Événements
Découvrir plus: Radar — signaux d'actions sous-évaluées · Académie d'Investissement — apprenez à analyser les actions